In-silico vaccine design against novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- COV2)...
In-silico vaccine design against novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- COV2) using immunoinformatics approach
About this item
Full title
Author / Creator
Publisher
Cuddalore: Journal of Pharmaceutical Sciences and Research
Journal title
Language
English
Formats
Publication information
Publisher
Cuddalore: Journal of Pharmaceutical Sciences and Research
Subjects
More information
Scope and Contents
Contents
The spike protein is a transmembrane glycoprotein that forms homotrimers on the viral surface and enables host-viral interaction by attaching to angiotensin-converting enzyme 2 (ACE2) receptor expressed in lower respiratory tract cells [12, 13]. In-complete attenuation can lead to additional safety concerns. [...]in-vitro and in-vivo cell-based tox...
Alternative Titles
Full title
In-silico vaccine design against novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- COV2) using immunoinformatics approach
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2574807105
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2574807105
Other Identifiers
E-ISSN
0975-1459
